(Q24673656)

English

In vitro antimicrobial activity of tigemonam, a new orally administered monobactam

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

In vitro antimicrobial activity of tigemonam, a new orally administered monobactam (English)

0 references

3

A L Barry

0 references

Peter C. Fuchs

series ordinal

1

object named as

P C Fuchs

0 references

Ronald N Jones

series ordinal

2

object named as

R N Jones

0 references

language of work or name

English

0 references

publication date

March 1988

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

32

0 references

issue

3

0 references

page(s)

346-9

0 references

cites work

Method of reliable determination of minimal lethal antibiotic concentrations

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172173

retrieved

28 September 2017

In vivo evaluation of tigemonam, a novel oral monobactam

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172173

retrieved

28 September 2017

In vitro evaluation of tigemonam, a novel oral monobactam

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172173

retrieved

28 September 2017

In vitro activity of azthreonam, a monobactam antibiotic

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172173

retrieved

30 May 2018

The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172173

retrieved

30 May 2018

Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172173

retrieved

30 May 2018

Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3259122

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3259122

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

PubMed publication ID

3259122

0 references

(Q24673656)

In vitro antimicrobial activity of tigemonam, a new orally administered monobactam

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)